CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) was the target of a large decrease in short interest in the month of October. As of October 30th, there was short interest totaling 6,360 shares, a decrease of 82.7% from the October 15th total of 36,668 shares. Based on an average daily trading volume, of 1,094,366 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are short sold.
CV Sciences Stock Performance
Shares of CVSI remained flat at $0.01 during midday trading on Thursday. The stock had a trading volume of 523,559 shares, compared to its average volume of 995,545. CV Sciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.10. The firm has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.03.
About CV Sciences
CV Sciences, Inc. is a life sciences company focused on hemp-derived cannabidiol (CBD) and other plant-based wellness products. The company markets its consumer products under the PlusCBD brand, which is designed to provide consumers with a range of CBD formats for everyday wellness. PlusCBD products have included CBD oil drops, softgels, gummies, capsules, topical creams and balms, and products intended for pets. The company has sold its products through e-commerce channels and retail distribution, primarily serving customers in the United States.
See Also
- Five stocks we like better than CV Sciences
- Tesla’s Plan to End Cybertruck Reveals Its Real Priorities
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
